NIFTY  8,907.85  0.32%
  SENSEX  28,761.60  0.35%
 CURRENCY  Rs  66.93/$ 70.86/€, 83.36/£
  GOLD  29,150.00  -0.52%
  SILVER  42,580.00  -0.75%
  DAX  11,827.60  0.60%
  FTSE  7,299.86  -0.00%
  CAC  4,864.99  -0.04%
  HANG SENG  23,963.60  -0.76%
  NIKKEI  19,381.40  0.68%
  Shanghai Composite  3,253.33  0.23%
  DOW JONES  20,624.10  0.02%
  NASDAQ  5,838.58  0.41%
  S&P 500  2,351.16  0.17%
GOVT OFFICIAL - Govt To Sell 5% Stake In Bharat Electronics On Feb 22 GOVT OFFICIAL - Govt Aims To Raise About Rs 1,600 Cr From BEL Divestment

Analysts Bullish On Sun Pharma

Video:

Play this video

October 10: Sun Pharma's stock is up 50% in the last six months and almost 75% in the last year. With the second-quarter earnings season around the corner, analysts have pegged very high ranges for the company’s revenue and profit growth. Watch this segment to know why Sun Pharma has seen the growth it has and why analysts think it is a promising pick.